SEC Form 4 · accession 0001728209-18-000002
AMERICAN BIO MEDICA CORP · ABMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Jerome
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 10:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896747
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Statutory Stock OptionF1,F2 | $0.10 | Jun 21, 2018 | J | 20,000 | A | Jun 21, 2019 | Jun 21, 2028 | Common Shares | 20,000 | 20,000 | D |
Explanation of responses
- F1The closing price of the Company's common shares on June 21, 2018 was $0.10.
- F2The stock option becomes 100% exercisable on June 21, 2019.